Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi International Journal of Cardiovascular ResearchISSN: 2324-8602
Hisashi Kai Author
Subjects of specialization
Affiliation
Antiplatelet therapy, Heart, Cardiac surgery
Hisashi Kai Department of Cardiology, Kurume University Medical Center 155-1 Kokubu-machi, Kurume, Fukuoka 839-0863, Japan
Biography
Hisashi Kai
Department of Cardiology, Kurume University Medical Center 155-1 Kokubu-machi, Kurume, Fukuoka 839-0863, Japan Brain hemorrhage is a serious complication of antiplatelet therapy, particularly dual antiplatelet therapy (DAPT), in patients with coronary artery disease (CAD) who undergo percutaneous coronary intervention (PCI).
Publications
Research Article Open Access
Cerebral Micro bleeds in Coronary Artery Disease Patients during Antiplatelet Therapy
Author(s): Yoshiko Iwamoto, Hisashi Kai*, Kenji Fukuda, Hiroki Uchiwa, Takahiro Anegawa, Yuji Aoki, Hidemi Kajimoto, Yusuke Uchiyama, Toshi Abe, Tsutomu Imaizumi and Yoshihiro Fukumoto
Background: Brain hemorrhage is a serious complication of antiplatelet therapy, particularly dual antiplatelet therapy (DAPT), in patients with coronary artery disease (CAD) who undergo percutaneous coronary intervention (PCI). It has been suggested that cerebral micro bleeds (CMBs) detected on magnetic resonance imaging (MRI) are a risk factor for future cerebral haemorrhage. However, little is known about CMBs in CAD patients during antiplatelet therapy. We investigated the temporal changes of CMBs and determined the risk factors for CMBs in patients with CAD on antiplatelet therapy.
Methods: This study prospectively enrolled 14 CAD patients who underwent antiplatelet therapy (DAPT in 13 patients) and had no history of symptomatic stroke. Brai... view more»
Google Scholars / Researchers Sites
